For information about COVID-19, including symptoms and prevention, please read our COVID-19 patient guide. Please also consider supporting Weill Cornell Medicine’s efforts against the pandemic.

Outcomes after acute symptomatic seizures in neonates.

TitleOutcomes after acute symptomatic seizures in neonates.
Publication TypeJournal Article
Year of Publication2018
AuthorsGlass HC, Grinspan ZM, Shellhaas RA
JournalSemin Fetal Neonatal Med
Volume23
Issue3
Pagination218-222
Date Published2018 Jun
ISSN1878-0946
Abstract

Acute symptomatic seizures are a common sign of neurological dysfunction and brain injury in neonates and occur in approximately one to three per 1000 live births. Seizures in neonates are usually a sign of underlying brain injury and, as such, are commonly associated with adverse outcomes. Neurological morbidities in survivors often co-occur; epilepsy, cerebral palsy, and intellectual disability often occur together in the most severely affected children. Risk factors for adverse outcome include prematurity, low Apgar scores, low pH on the first day of life, seizure onset <24 or >72 h after birth, abnormal neonatal neurological examination, abnormal neonatal electroencephalographic background, status epilepticus, and presence and pattern of brain injury (particularly deep gray or brainstem injury). Despite this list of potential indicators, accurate prediction of outcome in a given child remains challenging. There is great need for long-term, multicenter studies to examine risk factors for, and pathogenesis of, adverse outcomes following acute symptomatic seizures in neonates.

DOI10.1016/j.siny.2018.02.001
Alternate JournalSemin Fetal Neonatal Med
PubMed ID29454756
Category: 
Faculty Publication